Lisinopril

Overview

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily in the treatment of high blood pressure and heart failure. It helps to relax blood vessels, making it easier for the heart to pump blood.

API suppliers (25)

Suppliers of Lisinopril backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Lupin LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• UNIMARK REMEDIES LTD1 active DMF
• Lupin LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• EVONIK OPERATIONS GMBHGermany1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• EVONIK OPERATIONS GMBHGermany1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Lupin LimitedIndia1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• UNIMARK REMEDIES LTD1 active DMF
• EVONIK OPERATIONS GMBHGermany1 active DMF
• ZENECA PHARMACEUTICALS
• FARMHISPANIA SA
• MYLAN LABORATORIES LTD
• Gedeon RichterHungary
• ESTEVE QUIMICA SA
• Sun Pharmaceutical Industries LimitedIndia
• Ipca Laboratories LimitedIndia
• Aurobindo Pharma LimitedIndia

Patent & exclusivity (US)

Per the FDA Orange Book (79 approved US products), the latest listed US patent on Lisinopril expires 6 Nov 2035. Generic API sourcing typically opens up once these lapse.

Therapeutic areas